- Home
- PCLA vs BOLD Comparison
PCLA vs BOLD Comparison
Compare PCLA & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCLA
- BOLD
- Stock Information
- Founded
- PCLA 2008
- BOLD 2018
- Country
- PCLA Japan
- BOLD United States
- Employees
- PCLA N/A
- BOLD N/A
- Industry
- PCLA Building Products
- BOLD
- Sector
- PCLA Consumer Discretionary
- BOLD
- Exchange
- PCLA Nasdaq
- BOLD Nasdaq
- Market Cap
- PCLA 71.3M
- BOLD 24.4M
- IPO Year
- PCLA 2025
- BOLD 2024
- Fundamental
- Price
- PCLA $0.73
- BOLD $1.14
- Analyst Decision
- PCLA
- BOLD Buy
- Analyst Count
- PCLA 0
- BOLD 3
- Target Price
- PCLA N/A
- BOLD $4.00
- AVG Volume (30 Days)
- PCLA 3.7M
- BOLD 278.2K
- Earning Date
- PCLA 01-01-0001
- BOLD 08-11-2025
- Dividend Yield
- PCLA N/A
- BOLD N/A
- EPS Growth
- PCLA N/A
- BOLD N/A
- EPS
- PCLA N/A
- BOLD N/A
- Revenue
- PCLA $5,475,228.00
- BOLD N/A
- Revenue This Year
- PCLA N/A
- BOLD N/A
- Revenue Next Year
- PCLA N/A
- BOLD N/A
- P/E Ratio
- PCLA N/A
- BOLD N/A
- Revenue Growth
- PCLA 40.19
- BOLD N/A
- 52 Week Low
- PCLA $0.37
- BOLD $1.00
- 52 Week High
- PCLA $9.80
- BOLD $4.72
- Technical
- Relative Strength Index (RSI)
- PCLA N/A
- BOLD N/A
- Support Level
- PCLA N/A
- BOLD N/A
- Resistance Level
- PCLA N/A
- BOLD N/A
- Average True Range (ATR)
- PCLA 0.00
- BOLD 0.00
- MACD
- PCLA 0.00
- BOLD 0.00
- Stochastic Oscillator
- PCLA 0.00
- BOLD 0.00
About PCLA PicoCELA Inc. American Depositary Shares
PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.